Ira A. Rosenberg is a Member of Sills Cummis & Gross and Co-Chair of the Corporate Practice Group and Chair of the Life Sciences Practice Group. Mr. Rosenberg has more than 30 years’ experience representing life science and health care technology companies, ranging in size from start-ups to public companies, in corporate and intellectual property transactions and general corporate matters. This work has included numerous product and technology acquisition, development, licensing, supply and distribution transactions, venture capital financings, mergers and acquisitions, strategic alliances and joint ventures. He has structured and negotiated corporate partnering transactions with numerous global and other large pharmaceutical companies. He has been recognized by Chambers USA 2008-2022 for New Jersey Corporate/M&A, The Best Lawyers in America 2001-2023 for Corporate Law; Mergers and Acquisitions Law, IFLR1000 United States: Guide to USA’s Leading Financial and Corporate Law Firms 2018-2022 for “Highly Regarded” New Jersey M&A and New Jersey Super Lawyers 2005-2020 for Mergers & Acquisitions; Securities & Corporate Finance. See Award Methodology. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Member, New York Chapter of the Association for Corporate Growth